SHINGRIX Recombinant Varicella Zoster Virus glycoprotein E antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection (289257)

ARTG ID

289257

ARTG Name

SHINGRIX Recombinant Varicella Zoster Virus glycoprotein E antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection

Sponsor

GlaxoSmithKline Australia Pty Ltd

ARTG Date

July 2, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GLAXOSMITHKLINE AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/35fd0811023714d5db29d6e78350f5af.pdf

https://medical-cdn.nocode.com/drug_tga/221fc746786b80f4f5314a13e49b2b69.pdf

Ingredient Name

Recombinant Varicella Zoster Virus glycoprotein E antigen